2-Phenyl-3,5-dimethylmorpholine is a drug with
stimulant
Stimulants (also often referred to as psychostimulants or colloquially as uppers) is an overarching term that covers many drugs including those that increase activity of the central nervous system and the body, drugs that are pleasurable and inv ...
and
anorectic
An anorectic or anorexic is a drug which reduces appetite, resulting in lower food consumption, leading to weight loss. By contrast, an appetite stimulant is referred to as orexigenic.
The term is (from the Greek ''ἀν-'' (an-) = "without" ...
effects, related to
phenmetrazine
Phenmetrazine (INN, USAN, BAN) (brand name Preludin, and many others) is a stimulant drug first synthesized in 1952 and originally used as an appetite suppressant, but withdrawn from the market in the 1980s due to widespread abuse. It was initia ...
. Based on what is known from other phenylmorpholines with similar structure, it likely acts as a
norepinephrine-dopamine releasing agent and may produce effects similar or slightly different to phenmetrazine.
See also
*
3-Fluorophenmetrazine
3-Fluorophenmetrazine (also known as 3-FPM, 3-FPH and PAL-593) is a phenylmorpholine-based stimulant and fluorinated analogue of phenmetrazine that has been sold online as a designer drug.
Chemistry
3-Fluorophenmetrazine is a fluorinated anal ...
*
G-130
G-130 (GP-130, 2-Phenyl-5,5-dimethyltetrahydro-1,4-oxazine) is a drug with stimulant and anorectic effects, related to phenmetrazine.
Structural analogs
Compounds related to G-130 and radafaxine were synthesized that behave as combined inhi ...
(2-Phenyl-5,5-dimethylmorpholine)
* 3,4-
Phendimetrazine
Phendimetrazine (Bontril, Adipost, Anorex-SR, Appecon, Melfiat, Obezine, Phendiet, Plegine, Prelu-2, Statobex) is a stimulant drug of the morpholine chemical class used as an appetite suppressant.
Pharmacology
Phendimetrazine functions as a p ...
(2-Phenyl-3,4-dimethylmorpholine)
*
3,6-Phendimetrazine (2-Phenyl-3,6-dimethylmorpholine)
*
4-Methylphenmetrazine
*
Manifaxine
Manifaxine (developmental code name GW-320,659) is a norepinephrine–dopamine reuptake inhibitor developed by GlaxoSmithKline through structural modification of radafaxine, an isomer of hydroxybupropion and one of the active metabolites of b ...
*
Radafaxine
*
Viloxazine
References
Anorectics
Stimulants
Substituted amphetamines
Phenylmorpholines
{{nervous-system-drug-stub